Deep vein thrombosis in a transgender woman.

about

The authors respond to "Adverse health outcomes in transgender people".Adverse health outcomes in transgender people.Primary Sigmoid Vaginoplasty in Transwomen: Technique and Outcomes.

P2860

Q47741378-7F2607E0-7C66-463C-BB04-E4960D3B9CA7 Q47741387-A5021979-A856-4F4D-B423-AC361D8AD842 Q55021044-993988A8-C930-4072-8582-AAC024F47838

P2860

Deep vein thrombosis in a transgender woman.

Item

http://www.wikidata.org/entity/Q50927397

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Deep vein thrombosis in a transgender woman.

@en

Deep vein thrombosis in a transgender woman.

@nl

type

Item

label

Deep vein thrombosis in a transgender woman.

@en

Deep vein thrombosis in a transgender woman.

@nl

prefLabel

Deep vein thrombosis in a transgender woman.

@en

Deep vein thrombosis in a transgender woman.

@nl

P1476

Deep vein thrombosis in a transgender woman.

@en

P2093

Alasdair Drummond

http://www.w3.org/2001/XMLSchema#string

Wesley Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City

Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

The controversy of managing calf vein thrombosis.

Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.

Safety of hormonal treatment in transgenders.

Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline

P304

E502-E504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.160408

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

Martina Kelly

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28385895

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

5378510

http://www.w3.org/2001/XMLSchema#string

Deep vein thrombosis in a transgender woman.

about

P2860

P2860

Deep vein thrombosis in a transgender woman.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932